399 related articles for article (PubMed ID: 25487856)
1. Fuse binding protein antagonizes the transcription activity of tumor suppressor protein p53.
Dixit U; Liu Z; Pandey AK; Kothari R; Pandey VN
BMC Cancer; 2014 Dec; 14():925. PubMed ID: 25487856
[TBL] [Abstract][Full Text] [Related]
2. FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53.
Dixit U; Pandey AK; Liu Z; Kumar S; Neiditch MB; Klein KM; Pandey VN
J Virol; 2015 Aug; 89(15):7905-21. PubMed ID: 25995247
[TBL] [Abstract][Full Text] [Related]
3. YY1/BCCIP Coordinately Regulates P53-Responsive Element (p53RE)-Mediated Transactivation of p21
Sui Y; Wu T; Li F; Wang F; Cai Y; Jin J
Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035388
[TBL] [Abstract][Full Text] [Related]
4. BCCIP functions through p53 to regulate the expression of p21Waf1/Cip1.
Meng X; Lu H; Shen Z
Cell Cycle; 2004 Nov; 3(11):1457-62. PubMed ID: 15539944
[TBL] [Abstract][Full Text] [Related]
5. Roles of BCCIP deficiency in mammary tumorigenesis.
Droz-Rosario R; Lu H; Liu J; Liu NA; Ganesan S; Xia B; Haffty BG; Shen Z
Breast Cancer Res; 2017 Oct; 19(1):115. PubMed ID: 29047390
[TBL] [Abstract][Full Text] [Related]
6. Differential BCCIP gene expression in primary human ovarian cancer, renal cell carcinoma and colorectal cancer tissues.
Liu X; Cao L; Ni J; Liu N; Zhao X; Wang Y; Zhu L; Wang L; Wang J; Yue Y; Cai Y; Jin J
Int J Oncol; 2013 Dec; 43(6):1925-34. PubMed ID: 24101097
[TBL] [Abstract][Full Text] [Related]
7. ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the far upstream element binding protein 1 in hepatocellular carcinoma is required for tumor growth.
Rabenhorst U; Beinoraviciute-Kellner R; Brezniceanu ML; Joos S; Devens F; Lichter P; Rieker RJ; Trojan J; Chung HJ; Levens DL; Zörnig M
Hepatology; 2009 Oct; 50(4):1121-9. PubMed ID: 19637194
[TBL] [Abstract][Full Text] [Related]
9. Human INO80/YY1 chromatin remodeling complex transcriptionally regulates the BRCA2- and CDKN1A-interacting protein (BCCIP) in cells.
Su J; Sui Y; Ding J; Li F; Shen S; Yang Y; Lu Z; Wang F; Cao L; Liu X; Jin J; Cai Y
Protein Cell; 2016 Oct; 7(10):749-760. PubMed ID: 27535137
[TBL] [Abstract][Full Text] [Related]
10. Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.
Hirata H; Sugimachi K; Komatsu H; Ueda M; Masuda T; Uchi R; Sakimura S; Nambara S; Saito T; Shinden Y; Iguchi T; Eguchi H; Ito S; Terashima K; Sakamoto K; Hirakawa M; Honda H; Mimori K
Cancer Res; 2016 Jun; 76(11):3265-76. PubMed ID: 27197151
[TBL] [Abstract][Full Text] [Related]
11. Tumor-suppressor effect of interferon regulatory factor-1 in human hepatocellular carcinoma.
Moriyama Y; Nishiguchi S; Tamori A; Koh N; Yano Y; Kubo S; Hirohashi K; Otani S
Clin Cancer Res; 2001 May; 7(5):1293-8. PubMed ID: 11350897
[TBL] [Abstract][Full Text] [Related]
12. PI3K/AKT/mTOR-dependent stabilization of oncogenic far-upstream element binding proteins in hepatocellular carcinoma cells.
Samarin J; Laketa V; Malz M; Roessler S; Stein I; Horwitz E; Singer S; Dimou E; Cigliano A; Bissinger M; Falk CS; Chen X; Dooley S; Pikarsky E; Calvisi DF; Schultz C; Schirmacher P; Breuhahn K
Hepatology; 2016 Mar; 63(3):813-26. PubMed ID: 26901106
[TBL] [Abstract][Full Text] [Related]
13. Ku80 functions as a tumor suppressor in hepatocellular carcinoma by inducing S-phase arrest through a p53-dependent pathway.
Wei S; Xiong M; Zhan DQ; Liang BY; Wang YY; Gutmann DH; Huang ZY; Chen XP
Carcinogenesis; 2012 Mar; 33(3):538-47. PubMed ID: 22226916
[TBL] [Abstract][Full Text] [Related]
14. Abrogation of the transactivation activity of p53 by BCCIP down-regulation.
Meng X; Yue J; Liu Z; Shen Z
J Biol Chem; 2007 Jan; 282(3):1570-6. PubMed ID: 17135243
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma--survival and clinical characteristics in relation to various histologic molecular markers in Western patients.
Schöniger-Hekele M; Hänel S; Wrba F; Müller C
Liver Int; 2005 Feb; 25(1):62-9. PubMed ID: 15698400
[TBL] [Abstract][Full Text] [Related]
16. PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21.
Hu F; Gartenhaus RB; Eichberg D; Liu Z; Fang HB; Rapoport AP
Oncogene; 2010 Oct; 29(40):5464-74. PubMed ID: 20622899
[TBL] [Abstract][Full Text] [Related]
17. RBP-J-interacting and tubulin-associated protein induces apoptosis and cell cycle arrest in human hepatocellular carcinoma by activating the p53-Fbxw7 pathway.
Wang H; Yang Z; Liu C; Huang S; Wang H; Chen Y; Chen G
Biochem Biophys Res Commun; 2014 Nov; 454(1):71-7. PubMed ID: 25445601
[TBL] [Abstract][Full Text] [Related]
18. Far upstream element-binding protein 1 is a prognostic biomarker and promotes nasopharyngeal carcinoma progression.
Liu ZH; Hu JL; Liang JZ; Zhou AJ; Li MZ; Yan SM; Zhang X; Gao S; Chen L; Zhong Q; Zeng MS
Cell Death Dis; 2015 Oct; 6(10):e1920. PubMed ID: 26469968
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of G1 to S cell cycle progression by BCCIP beta.
Meng X; Liu J; Shen Z
Cell Cycle; 2004 Mar; 3(3):343-8. PubMed ID: 14726710
[TBL] [Abstract][Full Text] [Related]
20. MYCN-mediated overexpression of mitotic spindle regulatory genes and loss of p53-p21 function jointly support the survival of tetraploid neuroblastoma cells.
Gogolin S; Batra R; Harder N; Ehemann V; Paffhausen T; Diessl N; Sagulenko V; Benner A; Gade S; Nolte I; Rohr K; König R; Westermann F
Cancer Lett; 2013 Apr; 331(1):35-45. PubMed ID: 23186832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]